Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes

Clinical and Experimental Immunology

Volumn 131, Issue 2, 2003, Pages 241-247

  Mattsson, L ^a   Lundberg, K ^a   Mussener E ^a   Jansson, A ^a   Erlandsson Harris, H ^a   Larsson, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Autoimmunity; Cell populations; Cytokines; Inhibition; Unrelated antigen

Indexed keywords

COLLAGEN TYPE 2; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGENS; ANTIGENS, CD27; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; COLLAGEN; CYTOKINES; FEMALE; FLOW CYTOMETRY; FREUND'S ADJUVANT; IMMUNOPHENOTYPING; INTERLEUKIN-4; LYMPH NODES; OVALBUMIN; RATS; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TH2 CELLS; UP-REGULATION;

EID: 0037318035     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02054.x     Document Type: Article

References (38)

1. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990; 33:693-701.
2. Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum 1982; 25:911-16.
3. Goldschmidt TJ, Holmdahl R. Therapeutic effects of monoclonal antibodies to alpha beta TCR but not to CD4 on collagen-induced arthritis in the rat. Cell Immunol 1994; 154:240-8.
4. Holmdahl R, Vingsbo C, Mo JA et al. Chronicity of tissue-specific experimental autoimmune disease: a role for B cells? Immunol Rev 1995; 144:109-35.
5. Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111:521-6.
6. Mussener Å, Klareskog L, Lorentzen JC, Kleinau S. TNF-α dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis. Scand J Immunol 1995; 42:128-34.
7. Mattsson L, Lorentzen JC, Svelander L et al. Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response. Scand J Immunol 1997; 46:619-24.
8. Persson S, Mikulowska A, Narula S, Ogarra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996; 44:607-14.
9. Mussener Å, Lorentzen JC, Kleinau S, Klareskog L. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997; 27:695-9.
10. Lorentzen JC, Erlandsson H, Mussener Å et al. Specific and long-lasting protection from collagen-induced arthritis and oil-induced arthritis in DA rats by administration of immunogens. Scand J Immunol 1995; 42:82-9.
11. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 1997; 185:901-7.
12. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975; 166:181-6.
13. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990; 20:1061-6.
14. Åkerlund K, Erlandsson Harris H, Tracey KJ et al. Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 1999; 115:32-41.
15. Lorentzen JC, Klareskog L. Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand J Immunol 1996; 44:592-8.
16. Larsson P, Mattsson L, Klareskog L, Johnsson C. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 1998; 114:277-83.
17. Svelander L, Holm BC, Bucht A, Lorentzen JC. Responses of rat immune system to arthritogenic adjuvant oil. Scand J Immunol 2001; 54:599-605.
18. Firth SA, Morgan K, Evans HB, Holt PJ. IgG subclasses in collagen-induced arthritis in the rat. Immunol Lett 1984; 7:243-7.
19. - thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur J Immunol 1996; 26:2702-8.
20. + T cells in autoimmunity. Ciba Found Symp 1995; 195:173-82.
21. Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF α, anti-IL-1 α/β, and IL-1Ra. Arthritis Rheum 1996; 39:797-809.
22. Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 1999; 163:5049-55.
23. + T cells. Immunology 1999; 97:466-73.
24. Horsfall AC, Butler DM, Marinova L et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997; 159:5687-96.
25. Lubberts E, Joosten LA, Chabaud M et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 2000; 105:1697-710.
26. + T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627-36.
27. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998; 187:1047-56.
28. Fujihashi K, Dohi T, Kweon MN et al. γδ T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int Immunol 1999; 11:1907-16.
29. Gramaglia I, Weinberg AD, Lemon M, Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998; 161:6510-17.
30. Ohshima Y, Yang LP, Uchiyama T et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 1998; 92:3338-45.
31. Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998; 188:297-304.
32. Akiba H, Miyahira Y, Atsuta M et al. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med 2000; 191:375-80.
33. Malmström V, Shipton D, Singh B et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol 2001; 166:6972-81.
34. Mackay CR. Immunological memory. Adv Immunol 1993; 53:217-65.
35. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Memory B and T cells. Ann Rev Immunol 1991; 9:193-217.
36. Mackay CR. Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993; 5:423-7.
37. Arbones ML, Ord DC, Ley K et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1:247-60.
38. Mattsson L, Larsson P, Erlandsson Harris H, Klareskog L, Harris RA. Parasite-mediated down-regulation of collagen-induced arthritis (CIA) in DA rats. Clin Exp Immunol 2000; 122:477-83.